Rebecca B. Perkins, MD, MSc

Associate Professor, Obstetrics & Gynecology

Rebecca Perkins
85 E. Concord St


My area of research is cervical cancer prevention in underserved women. My current work focuses on HPV vaccination in females and males, as well as the impact of new screening guidelines on cervical dysplasia/cancer outcomes.

Other Positions

  • Member, BU-BMC Cancer Center, Boston University



  • Harvard Medical School, MD
  • Boston University School of Public Health, MSc
  • Stanford University, BA


  • Published on 1/1/2022

    Casey SM, Jansen E, Drainoni ML, Schuch TJ, Leschly KS, Perkins RB. Long-Term Multilevel Intervention Impact on Human Papillomavirus Vaccination Rates Spanning the COVID-19 Pandemic. J Low Genit Tract Dis. 2022 Jan 01; 26(1):13-19. PMID: 34928249.

    Read at: PubMed
  • Published on 12/6/2021

    Aninye IO, Berry-Lawhorn JM, Blumenthal P, Felder T, Jay N, Merrill J, Messman JB, Nielsen S, Perkins R, Rowen T, Saslow D, Trimble CL, Smith-McCune K. Gaps and Opportunities to Improve Prevention of Human Papillomavirus-Related Cancers. J Womens Health (Larchmt). 2021 Dec; 30(12):1667-1672. PMID: 34871035.

    Read at: PubMed
  • Published on 10/9/2021

    Fuss TL, Devera JL, Pierre-Joseph N, Perkins RB. Attitudes and Communication Preferences for Vaccines among Pregnant Women Receiving Care at a Safety-net Hospital. Womens Health Issues. 2022 Jan-Feb; 32(1):67-73. PMID: 34635378.

    Read at: PubMed
  • Published on 10/1/2021

    Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M. Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2021 10 01; 25(4):330-331. PMID: 34542089.

    Read at: PubMed
  • Published on 9/20/2021

    Munshi VN, Perkins RB, Sy S, Kim JJ. Cost-effectiveness analysis of the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Am J Obstet Gynecol. 2021 Sep 20. PMID: 34547295.

    Read at: PubMed
  • Published on 8/18/2021

    Perkins RB, Adcock R, Benard V, Cuzick J, Waxman A, Howe J, Melkonian S, Gonzales J, Wiggins C, Wheeler CM. Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations. Prev Med. 2021 Dec; 153:106770. PMID: 34416221.

    Read at: PubMed
  • Published on 7/1/2021

    Fowler ML, Wang D, Chia V, Handal-Orefice R, Latortue-Albino P, Mulekar S, White K, Perkins R. Management of Cervical Ectopic Pregnancies: A Scoping Review. Obstet Gynecol. 2021 07 01; 138(1):33-41. PMID: 34259461.

    Read at: PubMed
  • Published on 7/1/2021

    Drainoni ML, Biancarelli D, Jansen E, Bernstein J, Joseph N, Eun TJ, Fenton AHTR, Clark JA, Hanchate A, Legler A, Schuch TJ, Leschly K, Perkins RB. Provider and Practice Experience Integrating the Dose-HPV Intervention into Clinical Practice. J Contin Educ Health Prof. 2021 07 01; 41(3):195-201. PMID: 33973928.

    Read at: PubMed
  • Published on 6/30/2021

    Wentzensen N, Clarke MA, Perkins RB. Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities. Prev Med. 2021 10; 151:106596. PMID: 34217415.

    Read at: PubMed
  • Published on 6/30/2021

    Fisher-Borne M, Isher-Witt J, Comstock S, Perkins RB. Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects. Prev Med. 2021 10; 151:106681. PMID: 34217422.

    Read at: PubMed

View 105 more publications: View full profile at BUMC

View all profiles